Back to search results

Fruit and Vegetable Vouchers for Children with MASLD and Food Insecurity

This study is looking at how providing fruit and vegetable vouchers can help children aged 6 to 17 who have metabolic dysfunction-associated steatotic liver disease (MASLD) and live in families experiencing food insecurity. MASLD is a liver condition often linked to diet. Participants will receive $80 worth of fruit/vegetable vouchers (EatSF Veggies4Vouchers) each month for six months. Researchers will measure how much the vouchers are used, changes in what children eat, and improvements in liver inflammation and other heart-related health factors. To join, your family must live in California, and a parent/guardian must speak English or Spanish. Your child needs to be between 6 and 17 years old, have an elevated BMI, and an elevated ALT value (a liver enzyme).

Study design
This is a 6-month pilot study involving 48 participants. It is a single-arm intervention, meaning all participants receive the fruit/vegetable vouchers.
What's involved
You will participate in this study for six months, receiving vouchers and completing assessments at the beginning and end of this period.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for six months, from enrollment to the end of the intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07091539

Food Insecurity and MASLD: A Fruit and Vegetable Intervention Study

Recruiting
NAAges 6–17InterventionalHealth services
University of California, San Francisco
~48 participants
Updated 2025-09-02 on ClinicalTrials.gov
What's tested:Fruit/vegetable vouchers

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Voucher participation
Measured over From enrollment to the end of the six month intervention
+2 more outcomes measured

Conditions

MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease
Food Insecurity Among Children

Explore related trials

Food InsecurityNonalcoholic Fatty Liver Disease

NCT07091539

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • University of California, San Francisco

    San Francisco, Californiano site contact published

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Sarah L Maxwell, MD · PRINCIPAL_INVESTIGATOR · University of California, San Francisco

Who to contact

Milagro Escobar
[email protected]
4155197863
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

The study population for all study aims consists of children and adolescents receiving care at the liver and WATCH clinics.
family living in California;
a parent/guardian who speaks Spanish or English,
child is between the ages of 6 to \<18 years;
child has elevated BMI greater than or equal to 85% for age and sex
child has ALT value greater than 26 for boys and 22 for girls on two occasions within the last year; OR one elevated ALT value and imaging confirming steatosis
family does not intend to move out of California for the next year;
family is not already receiving EatSF Fruit and Vegetable Vouchers;
family is not participating in any other dietary education programs besides that offered by the liver/ WATCH clinics

Exclusion

child has an underlying condition or medication causing their weight gain (i.e., hypothyroidism, Prader-Willi syndrome, antipsychotic medications) or a known liver condition other than MASLD/MASH causing their elevated liver numbers;
child is on a weight loss medication (including: Qsymia or GLP-1 receptor agonists),
both of which are assessed as part of routine clinical care.

What this trial measures

  • Voucher participationFrom enrollment to the end of the six month intervention

    What percentage of money of the vouchers were used monthly

  • Changes in dietary intakeFrom baseline to the end of the six month intervention

    Assess changes in dietary intake in children with MASLD and FI participating in the 6 month pre-post one arm pilot intervention studies.

  • changes in liver inflammation and other cardiometabolic health factorsFrom baseline to the end of the six months study.

    Assess changes in liver inflammation as measured by ALT and GGT and other cardiometabolic health factors in children with MASLD and FI from baseline to the end of the six months study.